Advances in revascularization for peripheral artery disease: revascularization in PAD

JA Beckman, PA Schneider, MS Conte - Circulation research, 2021 - Am Heart Assoc
Effective revascularization of the patient with peripheral artery disease is about more than
the procedure. The approach to the patient with symptom-limiting intermittent claudication or …

Current therapeutic strategies in diabetic foot ulcers

A Perez-Favila, ML Martinez-Fierro… - Medicina, 2019 - mdpi.com
Diabetic foot ulcers (DFUs) are the fastest growing chronic complication of diabetes mellitus,
with more than 400 million people diagnosed globally, and the condition is responsible for …

[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

[HTML][HTML] The Society for Vascular Surgery clinical practice guidelines on popliteal artery aneurysms

A Farber, N Angle, E Avgerinos, L Dubois… - Journal of vascular …, 2022 - Elsevier
Abstract The Society for Vascular Surgery clinical practice guidelines on popliteal artery
aneurysms (PAAs) leverage the work of a panel of experts chosen by the Society for …

Tissue engineering of small-diameter vascular grafts and their in vivo evaluation in large animals and humans

S Fang, DG Ellman, DC Andersen - Cells, 2021 - mdpi.com
To date, a wide range of materials, from synthetic to natural or a mixture of these, has been
explored, modified, and examined as small-diameter tissue-engineered vascular grafts (SD …

Umbilical cord tissue cryopreservation: a short review

I Arutyunyan, T Fatkhudinov, G Sukhikh - Stem cell research & therapy, 2018 - Springer
In this review we present current evidence on the possibility of umbilical cord tissue
cryopreservation for subsequent clinical use. Protocols for obtaining umbilical cord-derived …

The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

Y Matsuzaki, R Iwaki, JW Reinhardt, YC Chang… - Acta Biomaterialia, 2020 - Elsevier
To date, there has been little investigation of biodegradable tissue engineered arterial grafts
(TEAG) using clinically relevant large animal models. The purpose of this study is to explore …

[HTML][HTML] Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

P Gutowski, M Guziewicz, M Ilzecki, A Kazimierczak… - JVS-Vascular …, 2023 - Elsevier
Objective The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II
study. The primary results at 24 months after implantation have been reported, and the …

[HTML][HTML] Editor's choice–follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European society of cardiology …

M Venermo, M Sprynger, I Desormais, M Björck… - European Journal of …, 2019 - Elsevier
Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

Disparities between international guidelines (AHA/ESC/ESVS/ESVM/SVS) concerning lower extremity arterial disease: Consensus of the French Society of Vascular …

G Mahé, G Boge, A Bura-Rivière, N Chakfé… - Annals of Vascular …, 2021 - Elsevier
Several international guidelines concerning lower extremity arterial disease (LEAD) have
been published recently, in particular, by the American Heart Association the European …